Why Is Quetiapine XR So Hard to Find? [Explained for 2026]

If you've been standing at the pharmacy counter — prescription in hand — only to be told "we don't have that in stock," you're not alone. Quetiapine XR (sold as Seroquel XR by AstraZeneca, and in generic form by multiple manufacturers) has been hard to find in certain pharmacies and markets over the past few years. In this guide, we break down the real reasons why this happens and what you can do about it.

What Exactly Is Quetiapine XR?

Quetiapine XR is the extended-release formulation of quetiapine fumarate, an atypical antipsychotic first approved by the FDA in 1997. While the immediate-release version (Seroquel) is taken two or three times daily, the XR formulation is taken once daily, typically in the evening. It's FDA-approved for schizophrenia, bipolar I disorder (mania, depression, and maintenance), and as an adjunctive treatment for major depressive disorder (MDD).

Because it's a once-daily medication with a specific extended-release matrix, the XR tablets cannot be crushed, split, or substituted with standard immediate-release quetiapine without a dosage adjustment and prescriber guidance. That unique formulation is one reason availability problems hit patients harder than with many other generic medications.

Has There Been an Official Quetiapine XR Shortage?

In the United States, quetiapine XR is manufactured by several generic companies and is generally available — the FDA has not listed an active national shortage as of early 2026. However, internationally the picture has been different. In early 2025, Australia experienced a nationwide shortage of several quetiapine strengths, with the Therapeutic Goods Administration (TGA) reporting limited supplies of 300 mg and 25 mg tablets. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) issued supply notifications in February 2025 for all modified-release quetiapine strengths (50 mg, 150 mg, 200 mg, 300 mg, and 400 mg). The European Medicines Agency (EMA) similarly flagged shortages of extended-release quetiapine tablets in several EU/EEA member states.

Even without a national US shortage, localized stocking issues are common. Not every pharmacy carries every strength, and smaller independent pharmacies may not stock the less-common doses (like 150 mg). Chain pharmacies vary their inventory by location and demand, so what's available at one Walgreens or CVS may not be at the next one.

Why Do Extended-Release Formulations Face More Availability Problems?

Extended-release tablets like Quetiapine XR are more complex to manufacture than their immediate-release counterparts. The XR version requires a specialized hydrophilic matrix technology that releases the active ingredient slowly over time. This added manufacturing complexity means:

Fewer manufacturers produce the XR formulation compared to the immediate-release version

Manufacturing disruptions at a single facility can create supply gaps across a region

Quality-control issues can trigger voluntary recalls that temporarily reduce supply

Less common strengths (e.g., 150 mg) may be stocked by fewer pharmacies

Why Is Quetiapine Used So Widely — And Why Does That Increase Demand?

Quetiapine is one of the most widely prescribed psychiatric medications in the United States. Its FDA approvals span schizophrenia, bipolar disorder, and major depressive disorder, but off-label use is extremely common — particularly for generalized anxiety disorder, insomnia, and PTSD. This broad prescribing pattern significantly increases demand, sometimes outpacing what pharmacy supply chains anticipate.

Additionally, because quetiapine XR is taken once daily (improving adherence), many prescribers prefer the XR version over the immediate-release tablets, especially for long-term management. This preference concentrates demand on a smaller manufacturing stream than the immediate-release market.

What Happens When Patients Can't Get Their Quetiapine XR?

Missing doses or abruptly stopping quetiapine can be medically serious. Quetiapine should not be stopped without medical supervision, as withdrawal symptoms — including nausea, vomiting, and insomnia — can occur. More importantly, untreated psychiatric illness can deteriorate rapidly. Patients who cannot fill their prescription should contact their prescriber immediately to discuss options including:

Switching temporarily to quetiapine immediate-release (with dose adjustment)

Trying a different pharmacy in the area that carries the medication in stock

Asking the pharmacy to order the specific strength if lead time allows

Considering a therapeutic alternative under prescriber guidance

How Can You Find Quetiapine XR in Stock Near You?

Rather than calling pharmacy after pharmacy yourself, medfinder does the legwork for you. You provide your medication, dosage, and ZIP code, and medfinder calls local pharmacies to find out which ones can actually fill your prescription. Results are texted directly to you — no hold music, no runaround.

For a deeper look at the tools and tips for finding Quetiapine XR, read our guide: How to Find Quetiapine XR in Stock Near You

Is Quetiapine XR Availability Improving in 2026?

In the US market, quetiapine XR availability has been relatively stable compared to some other psychiatric medications. Generic competition means multiple manufacturers compete for market share, which generally supports supply. That said, pharmacy-specific stocking decisions, local demand spikes, and supply chain hiccups mean that individual patients may still encounter trouble finding their specific strength at their usual pharmacy.

The bottom line: quetiapine XR isn't nationally scarce in the US, but localized stocking gaps are real and can be deeply disruptive for patients who depend on it. Knowing your options — and having a service like medfinder in your corner — makes all the difference.